Literature DB >> 17485110

Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.

Stefano Molica1, Giovanna Cutrona, Gaetano Vitelli, Rosanna Mirabelli, Matteo Molica, Giovanna Digiesi, Domenico Ribatti, Manlio Ferrarini, Angelo Vacca.   

Abstract

We wondered whether there was any association between the extent of increased angiogenesis and IgV(H) gene mutational status, expression of CD38 and ZAP-70 in early B-cell chronic lymphocytic leukemia (CLL) patients. Circulating levels of vascular endothelial growth factor (VEGF) correlated positively with ZAP-70-expression (P=0.03), CD38- expression (P=0.03) and mutational status of IgV(H) (P=0.005). The same did not apply when correlations were sought with either bone marrow angiogenesis or serum levels of basic fibroblatic growth factor (FGF-2). Studies to determine how to integrate variables reflecting increased angiogenesis with other prognostic markers such as CD38, ZAP-70, IgV(H) status and cytogenetic abnormalities are needed to optimize risk stratification for individual patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485110     DOI: 10.1016/j.leukres.2007.03.009

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia.

Authors:  Preetesh Jain; Hun Ju Lee; Wei Qiao; William Wierda; Ohad Benjamini; Jan Burger; Alessandra Ferrajoli; Zeev Estrov; Hagop Kantarjian; Michael Keating; Susan O'Brien
Journal:  Cancer       Date:  2014-07-15       Impact factor: 6.860

2.  Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.

Authors:  Farahnaz B Rahmatpanah; Stephanie Carstens; Sam I Hooshmand; Elise C Welsh; Ozy Sjahputera; Kristen H Taylor; Lynda B Bennett; Huidong Shi; J Wade Davis; Gerald L Arthur; Tait D Shanafelt; Neil E Kay; James E Wooldridge; Charles W Caldwell
Journal:  Epigenomics       Date:  2009-10       Impact factor: 4.778

3.  SOX11 expression in chronic lymphocytic leukemia correlates with adverse prognostic markers.

Authors:  Alejandro Roisman; Carmen Stanganelli; Virginia Palau Nagore; Guillermo Videla Richardson; María Elida Scassa; Raimundo Fernando Bezares; María Cabrejo; Irma Slavutsky
Journal:  Tumour Biol       Date:  2015-01-22

4.  Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia.

Authors:  Stefano Molica; Rosanna Mirabelli; Matteo Molica; Luciano Levato; Francesca R Mauro; Robin Foà
Journal:  Cancer Manag Res       Date:  2011-06-01       Impact factor: 3.989

5.  What role for angiogenesis in childhood acute lymphoblastic leukaemia?

Authors:  P Schneider; I Dubus; F Gouel; E Legrand; J P Vannier; M Vasse
Journal:  Adv Hematol       Date:  2011-11-09

6.  CD38 in cancer-associated fibroblasts promotes pro-tumoral activity.

Authors:  Bar Ben Baruch; Einav Mantsur; Janusz Franco-Barraza; Eran Blacher; Edna Cukierman; Reuven Stein
Journal:  Lab Invest       Date:  2020-07-01       Impact factor: 5.662

7.  Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?

Authors:  Stefano Molica; Giovanna Digiesi; Angelo Vacca; Rosanna Mirabelli; Katia Todoerti; Caterina Battaglia; Fortunato Morabito; Antonino Neri; Domenico Ribatti
Journal:  Adv Hematol       Date:  2009-08-27

8.  Host CD39 Deficiency Affects Radiation-Induced Tumor Growth Delay and Aggravates Radiation-Induced Normal Tissue Toxicity.

Authors:  Alina V Meyer; Diana Klein; Simone de Leve; Klaudia Szymonowicz; Martin Stuschke; Simon C Robson; Verena Jendrossek; Florian Wirsdörfer
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.